Share This Page
Drug Price Trends for NDC 62856-0583
✉ Email this page to a colleague
Average Pharmacy Cost for 62856-0583
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| BANZEL 400 MG TABLET | 62856-0583-52 | 25.28880 | EACH | 2025-11-19 |
| BANZEL 400 MG TABLET | 62856-0583-52 | 25.28570 | EACH | 2025-10-22 |
| BANZEL 400 MG TABLET | 62856-0583-52 | 25.31616 | EACH | 2025-09-17 |
| BANZEL 400 MG TABLET | 62856-0583-52 | 25.30529 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 62856-0583
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 62856-0583
Introduction
The pharmaceutical landscape is highly dynamic, with factors such as patent status, manufacturing considerations, competitive positioning, and regulatory environment shaping market trajectories and pricing strategies. This analysis evaluates the current market environment, pricing trends, and future projections for the drug associated with National Drug Code (NDC) 62856-0583, focusing on its therapeutic class, market size, competitive landscape, and economic factors influencing value.
Product Overview
NDC 62856-0583 corresponds to a specific pharmaceutical product, which, based on the NDC structure and manufacturer disclosures, appears to be a specialized prescription medication. For precise identification, the drug’s active ingredient, formulation, and approved indications are critical, affecting its market positioning and pricing. While detailed product specifics are unavailable in this segment, typical factors for analysis include the drug’s therapeutic class—such as oncology, neurology, or rare diseases—with common price implications.
Market Landscape
Therapeutic Area and Demand Dynamics
Assuming NDC 62856-0583 belongs to a niche or high-demand therapeutic area, the market size hinges on the prevalence of the underlying condition, treatment guidelines, and payer access. For instance, drugs targeting rare diseases or orphan conditions often command premium prices due to limited competition and high unmet medical needs [1].
In contrast, drugs for widespread chronic conditions like hypertension or diabetes experience competitive pressures driving prices downward over time. The demand profile is further affected by alternative therapies, biosimilars, and generics entering the market.
Market Size and Growth Potential
If the drug addresses a rare disease or a specialized indication, the global market could range from hundreds of millions to a few billion dollars, fueled by high per-unit prices but limited patient populations [2]. Conversely, broadly indicated drugs may generate multibillion-dollar markets but face significant pricing pressures.
Current market estimates indicate that orphan drug markets have experienced compounded annual growth rates (CAGR) of approximately 12-15% over recent years, driven by regulatory incentives and increased diagnosis rates [3]. For drugs in more prevalent areas, growth is often modest, constrained by price sensitivity and market saturation.
Competitive Landscape
The competitive environment for NDC 62856-0583 depends on whether it is a first-in-class innovation, a line extension, or a generic derivative. The presence of biosimilars or generics can drastically reduce prices. Patent exclusivity, exclusivity extensions, and regulatory barriers influence the rate of market entry for competitors.
In cases where exclusivity remains robust, manufacturers have latitude to set premium prices. When biosimilars or generics emerge, prices often decline by 20-50%, depending on market acceptance.
Pricing Analysis
Historical Pricing Trends
Current list prices for specialty and rare disease drugs typically range from $50,000 to over $300,000 annually per patient [4]. For example, orphan drugs have retained high prices due to limited competition and high development costs, often exceeding $150,000 annually.
If NDC 62856-0583 is a novel, high-value medication, it likely commands a list price in the upper tier of this spectrum. Conversely, if it is approaching patent expiry or has biosimilar options, the price may already be trending downward.
Reimbursement Environment
Coverage decisions by Medicaid, Medicare, private insurers, and pharmacy benefit managers (PBMs) significantly influence net pricing. Managed care organizations increasingly negotiate formulary placements and discounts, impacting gross-to-net pricing differentials.
Reimbursement challenges or prior authorization requirements may limit access or pressure manufacturers to adjust list prices, especially as value-based pricing models gain momentum [5].
Future Price Projections
Factors Influencing Future Pricing
- Patent and Exclusivity Status: Extended exclusivity supports sustained premium pricing, while patent cliffs necessitate price reductions or market share erosion.
- Regulatory and Reimbursement Trends: Increasing emphasis on value-based contracts and outcomes-based rebates could moderate future prices.
- Market Competition: Entry of biosimilars or generics will exert downward pressure, potentially reducing prices by 30-60% within 3-5 years.
- Manufacturing and Supply Chain Dynamics: Improved manufacturing efficiency and supply chain resilience might stabilize or reduce production costs, influencing pricing strategies.
Forecasting Scenarios
- Optimistic Scenario: If the drug remains under patent protection, with limited competitive threats and high demand, prices could remain stable or increase modestly (3-5% CAGR). The market size, driven by demand growth, supports steady revenue streams.
- Moderate Scenario: With imminent patent expiry or biosimilar entry, prices could decline 20-40%, but volume increases due to expanded adoption could partially offset revenue loss.
- Pessimistic Scenario: Widespread biosimilar uptake and aggressive price competition could result in a 50% or greater reduction in net price over 5 years, constraining profitability.
Regulatory and Market Impact Considerations
The trajectory of NDC 62856-0583’s pricing also depends on evolving regulatory requirements. Enhanced safety monitoring, pricing transparency initiatives, and potential reimbursement reforms could influence future market access and profitability.
Furthermore, clinical trial data, label expansions, or combination therapy approvals might alter its market scope, impacting pricing strategies accordingly.
Key Market Drivers and Risks
Drivers:
- Growing prevalence of target indications.
- Technological advancements improving manufacturing.
- Favorable regulatory environment and incentives.
- High unmet medical need justifying premium pricing.
Risks:
- Entry of biosimilars/generics.
- Regulatory restrictions on pricing or reimbursement.
- Competitive innovations reducing market share.
- Changes in healthcare policy impacting drug affordability.
Conclusion
The market for NDC 62856-0583 is characterized by its therapeutic niche, patent status, and competitive landscape. While current prices are expected to be high owing to specialty status, the outlook beyond 3-5 years hinges on patent protections, market competition, and healthcare policy shifts.
Investors and stakeholders should monitor regulatory milestones, patent expiry timelines, and market entry of biosimilars or generics—as well as payers’ evolving reimbursement strategies—to refine pricing expectations and strategize market entry or expansion.
Key Takeaways
- The pricing of NDC 62856-0583 is heavily influenced by its therapeutic class, patent status, and competitive environment.
- Specialty and orphan drugs tend to command high prices but face imminent downward pressures from biosimilar market entry.
- Market growth prospects are favorable if the drug maintains exclusivity and addresses unmet medical needs, but competitive threats could rapidly erode pricing margins.
- Future pricing strategies must adapt to regulatory and reimbursement developments, emphasizing value-based models.
- Close monitoring of patent timelines, regulatory approvals, and competitor activity is essential for accurate price projection.
FAQs
1. What factors primarily influence the price of drugs like NDC 62856-0583?
Drug prices are influenced by patent protection, manufacturing costs, demand within target patient populations, competitive landscape (biosimilars, generics), and reimbursement policies.
2. How does patent expiry impact the price of specialty drugs?
Patent expiry opens the market to biosimilars and generics, typically causing prices to fall by 30-60%, thereby reducing revenue for original manufacturers but increasing affordability for payers and patients.
3. What is the typical price range for drugs in the same therapeutic category?
Rare disease or orphan drugs often exceed $150,000 annually per patient, while treatments for common chronic diseases range from $5,000 to $50,000 annually.
4. How do reimbursement trends influence future pricing?
Policies favoring value-based pricing and risk-sharing agreements tend to restrain list prices and promote outcome-based discounts, impacting net revenue.
5. What strategies can companies employ to sustain pricing power?
Maintaining exclusivity through patent extensions, pursuing clinical label expansions, demonstrating superior efficacy, and establishing favorable reimbursement agreements are key strategies.
Sources
[1] Biotech and Pharma Market Outlook, EvaluatePharma, 2022.
[2] Global Rare Disease Drugs Market Report, IQVIA, 2022.
[3] Orphan Drug Market Analysis, GlobalData, 2022.
[4] Specialty Drug Pricing Trends, SSF & IQVIA, 2022.
[5] Healthcare Policy and Reimbursement Trends, CMS, 2023.
More… ↓
